Escherichia coli type 1 fimbrial adhesin (FimH) (FimH)

The term "Escherichia coli adhesion to uroepithelial cells" refers not to a single molecular target but rather a **pathogenic process** mediated primarily by specific surface proteins and organelles expressed by uropathogenic Escherichia coli (UPEC). The most studied and therapeutically relevant molecular target within this process is the **type 1 fimbrial adhesin FimH**, which is located at the tip of type 1 pili. These adhesive organelles—including type 1, P, and S pili as well as Dr family adhesins—enable E. coli to attach firmly to receptors such as integrins and uroplakins on the surface of bladder epithelial cells[1][3][4]. This attachment is essential for colonization, invasion into host tissues, biofilm formation within intracellular bacterial communities (IBCs), and evasion from immune responses[2][3]. Drugs like dictamnine have been shown experimentally to inhibit this adhesive interaction in vitro[4]. **Note:** There is something incorrect about using "Escherichia coli adhesion to uroepithelial cells" as a canonical therapeutic target name. It describes a biological process rather than a discrete molecule or receptor. The actual druggable targets are specific E. coli proteins such as FimH or other pilus-associated adhesins; these should be used for structured data purposes instead. > “Adhesive organelles including type 1...pili along with Dr adhesins promote both bacterial attachment...within the urinary tract.” [1] > “One of the main strategies...is targeting bacterial adhesion by inhibiting...FimH.” [3] > “UPEC adhere to urothelial cells through type 1 fimbriae which bind...to integrin and uroplakin receptors.” [4] If you need structured information for an actual molecular target involved in this process—such as "Escherichia coli type 1 fimbrial adhesin (FimH)"—please specify so that more precise data can be provided.

Other names

Uropathogenic Escherichia coli adhesinsType 1 fimbriaeP piliS piliDr adhesinsUPEC adhesion factors

Inhibition of bacterial adhesion to uroepithelial cells by blocking FimH or other fimbrial/adhesin interactions